Sir Charles Gairdner Hospital
In research, Sir Charles Gairdner Hospital stands highest in Health Sciences (#2,244 of 11,982 worldwide) and Medicine (#2,016 of 10,443 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 7.8× its share of world research.
- World rank, 2022–2025
- #6,708 of 28,054 · #5,692 all time
- Rank in Australia
- #112 of 391
- Research works
- 3.6k ▲ 4% vs 2013–17
- Citations
- 93k 25.8 per fractional work
- Top-10% rate
- 13.4% record average 16.5%
- Open access
- 39% world 28%
What is Sir Charles Gairdner Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #2,244 of 11,982 | 13.0% | 408 | #1415 | |
| MedicineField | #2,016 of 10,443 | 12.5% | 379 | #1200 |
Each strip is that field’s whole ranked pool, with the notch where Sir Charles Gairdner Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Sir Charles Gairdner Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 7.8× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 58.6 works7.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.
- Medicine 4.0×
- Health Professions 1.9×
- Immunology and Microbiology 1.7×
- Nursing 1.4×
- Pharmacology, Toxicology and Pharmaceutics 1.2×
- Biochemistry, Genetics and Molecular Biology 1.0×
- Neuroscience 1.0×
- Psychology 0.6×
- Physics and Astronomy 0.5×
- Veterinary 0.3×
- Dentistry 0.2×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Social Sciences 0.1×
- Mathematics 0.1×
- Materials Science 0.1×
- Business, Management and Accounting 0.1×
- Chemistry 0.0×
- Computer Science 0.0×
- Arts and Humanities 0.0×
- Decision Sciences 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Sir Charles Gairdner Hospital?
Ranked on the composite score, John P. Walsh, David R. Hillman and Alan James lead among researchers whose main affiliation is Sir Charles Gairdner Hospital.
- 1 John P. Walsh Australia · #23,536 worldwide 433 citations · 55 works
- 2 David R. Hillman Australia · #37,122 worldwide 292 citations · 47 works
- 3 Alan James Australia · #204,810 worldwide 110 citations · 20 works
- 4 Matthew Anstey Australia · #224,183 worldwide 123 citations · 20 works
- 5 Michael Byrne Australia · #227,150 worldwide 104 citations · 24 works
- 6 Neville W. Knuckey Australia · #287,581 worldwide 85 citations · 26 works
- 7 Κ.B. Shilkin Australia · #293,293 worldwide 69 citations · 24 works
- 8 Peter L. Thompson Australia · #312,478 worldwide 178 citations · 51 works
- 9 David Joseph Australia · #314,613 worldwide 74 citations · 25 works
- 10 Scott G. Wilson Australia · #349,388 worldwide 153 citations · 32 works
Which keywords describe research at Sir Charles Gairdner Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Chemotherapy, Prognostic Factors, Treatment, Radiotherapy, Inflammation and Immunotherapy.
- Intensive Care Unit
- Radiation Therapy
- Elderly Patients
- Hodgkin's Lymphoma
- Genetic Pathogenesis
- Gene Expression Profiling
- Molecular Profiling
- Tumor Microenvironment
- Rehabilitation
- Clinical Trials
- PET Imaging
- Mortality
- Complications
- Clinical Practice Guidelines
- Rituximab
- Prognostic Factors
- Management
- Quality of Life
- Treatment
- Inflammation
- Epidemiology
- Diagnosis
- Chemotherapy
- Immunotherapy
- Risk Factors
- Radiotherapy
- Cardiovascular Disease
- Guidelines
- Lymphoma
- Surgical Management
- Metabolic Syndrome
- Classification
- Genetic Mutations
- Prognosis
- Autoantibodies
- Echocardiography
- Health-related Quality of Life
- Critical Care
- Dosimetry
- Therapeutic Targets
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology47▲ 2.4×96 topics
- Inflammation26▲ 2.6×62 topics
- Diagnosis22▲ 4.9×36 topics
- Treatment22▲ 3.7×41 topics
- Chemotherapy20▲ 5.9×21 topics
- Quality of Life19▲ 2.6×37 topics
- Immunotherapy18▲ 5.2×18 topics
- Management18▲ 4.7×28 topics
- Risk Factors17▲ 3.2×24 topics
- Prognostic Factors17▲ 7.7×14 topics
- Radiotherapy16▲ 8.2×12 topics
- Rituximab14▲ 19×4 topics
- Cardiovascular Disease14▲ 2.5×28 topics
- Clinical Practice Guidelines13▲ 4.8×14 topics
- Guidelines13▲ 5.5×13 topics
- Complications12▲ 5.0×15 topics
- Lymphoma11▲ 14×3 topics
- Mortality11▲ 3.9×13 topics
- Surgical Management11▲ 5.4×17 topics
- PET Imaging11▲ 13×4 topics
- Metabolic Syndrome10▲ 2.5×20 topics
- Clinical Trials10▲ 3.0×14 topics
- Classification10▲ 4.3×6 topics
- Rehabilitation9▲ 4.8×11 topics
- Genetic Mutations9▲ 4.3×18 topics
- Tumor Microenvironment9▲ 4.1×8 topics
- Prognosis9▲ 5.5×9 topics
- Molecular Profiling9▲ 18×3 topics
- Autoantibodies8▲ 7.3×8 topics
- Gene Expression Profiling8▲ 20×2 topics
- Echocardiography8▲ 5.8×7 topics
- Genetic Pathogenesis8▲ 29×1 topic
- Health-related Quality of Life8▲ 6.7×5 topics
- Hodgkin's Lymphoma8▲ 29×1 topic
- Critical Care7▲ 6.5×8 topics
- Elderly Patients7▲ 8.5×4 topics
- Dosimetry7▲ 20×2 topics
- Radiation Therapy6▲ 10×5 topics
- Therapeutic Targets6▲ 8.5×7 topics
- Intensive Care Unit6▲ 10.0×4 topics
Which research topics does Sir Charles Gairdner Hospital publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Advanced Radiotherapy Techniques and Chronic Lymphocytic Leukemia Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 8 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 3 Advanced Radiotherapy Techniques Radiation 5 works
- 4 Chronic Lymphocytic Leukemia Research Genetics 5 works
- 5 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
- 6 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 4 works
- 7 CNS Lymphoma Diagnosis and Treatment Neurology 3 works
- 8 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 3 works
- 9 CAR-T cell therapy research Oncology 3 works
- 10 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Sir Charles Gairdner Hospital's research output changed?
Output in 2018–2022 was 4% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Perth
- The University of Western Australia
- Curtin University
- Murdoch University
- Edith Cowan University
- Royal Perth Hospital
- Princess Margaret Hospital for Children
- Government of Western Australia
- Fiona Stanley Hospital
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.